PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer

NCT05880082 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
118
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University